Drug Type Stem cell therapy |
Synonyms aSMDC - Innovacell Biotechnologie GmbH, autologous Skeletal Muscle Derived Cells - Innovacell Biotechnologie GmbH, ICEF 15 + [2] |
Target- |
Mechanism Cell replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Urinary Incontinence, Urge | Phase 3 | BG | 11 May 2022 | |
Urinary Incontinence, Urge | Phase 3 | DE | 11 May 2022 | |
Urinary Incontinence, Urge | Phase 3 | ES | 11 May 2022 | |
Urinary Incontinence, Urge | Phase 3 | SE | 11 May 2022 | |
Fecal Incontinence | Phase 2 | DE | 08 Sep 2013 |